Inhibition of phenylephrine-stimulated gluconeogenesis by chlorpromazine is mediated by alpha-adrenergic receptors.
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002135:Calcium-Binding Proteins / Q000502:physiology*; D002147:Calmodulin / Q000502:physiology*; D002462:Cell Membrane / Q000187:drug effects; D002478:Cells, Cultured; D002746:Chlorpromazine / Q000494:pharmacology*; D005943:Gluconeogenesis / Q000187:drug effects*; D008099:Liver / Q000378:metabolism*; D010656:Phenylephrine / Q000037:antagonists & inhibitors*; D011224:Prazosin / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*
D002135:Calcium-Binding Proteins; D002147:Calmodulin; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D010656:Phenylephrine; D002118:Calcium; D002746:Chlorpromazine; D011224:Prazosin